Inflammation Research

Papers
(The H4-Index of Inflammation Research is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
News186
From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases144
Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNβ1 transcription during macrophage activation103
Tissue-resident immune cells in the pathogenesis of multiple sclerosis65
CHRFAM7A expression in mice increases resiliency after injury55
IL10/AMPK pathway was associated with the hippocampal anti-inflammatory response to high-sugar and high-fat diet withdrawal54
HMGB1: key mediator in digestive system diseases51
Inhibition of glycolytic reprogramming suppresses innate immune-mediated inflammation in experimental amyotrophic lateral sclerosis51
IL-33, a neutrophil extracellular trap-related gene involved in the progression of diabetic kidney disease50
Mitochondrial damage causes inflammation via cGAS-STING signaling in ketamine-induced cystitis49
Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study48
Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis47
Kinin B1 receptor and TLR4 interaction in inflammatory response45
Single-cell hdWGCNA reveals a novel diagnostic model and signature genes of macrophages associated with chronic obstructive pulmonary disease44
Viperin deficiency promotes dendritic cell activation and function via NF-kappaB activation during Mycobacterium tuberculosis infection42
Unveiling the role of ABI3 and hub senescence-related genes in macrophage senescence for atherosclerotic plaque progression40
Immune-related genetic single-nucleotide polymorphisms contribute to prognosis and response to chemotherapy in patients with acute lymphoblastic leukemia38
Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis38
Viperin inhibits interferon-γ production to promote Mycobacterium tuberculosis survival by disrupting TBK1-IKKε-IRF3-axis and JAK-STAT signaling37
Pseudomonas aeruginosa outer membrane vesicles ameliorates lung ischemia–reperfusion injury by regulating the balance of regulatory T cells and Th17 cells through Tim-3 and TLR4/NF-κB pathway35
Paradoxical expression of NRP1 in decidual stromal and immune cells reveals a novel inflammation balancing mechanism during early pregnancy35
Serum from COVID-19 patients promotes endothelial cell dysfunction through protease-activated receptor 234
CD20+ T cells: an emerging T cell subset in human pathology34
The role of fatty acid metabolism on B cells and B cell-related autoimmune diseases33
The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target33
IL-1 receptor antagonist: etiological and drug delivery systems overview33
Long-chain acyl-CoA synthetase 4-mediated mitochondrial fatty acid metabolism and dendritic cell antigen presentation33
A suitable model to investigate acute neurological consequences of coronavirus infection32
Extracellular histones induce inflammation and senescence of vascular smooth muscle cells by activating the AMPK/FOXO4 signaling pathway31
The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stress30
The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications30
0.40708088874817